Pulmonary Tuberculosis
Infectious Disease·MeSH: Tuberculosis, Pulmonary
Prevalence
30.0 / 100K
5 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(4)
Phase 2(1)
| Drug | Company |
|---|---|
| bedaquiline | GH Research PLC (GHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Pulmonary Tuberculosis?
BioSniper tracks 5 drugs in development for Pulmonary Tuberculosis across 2 companies.
How many clinical trials target Pulmonary Tuberculosis?
There are 1 clinical trial targeting Pulmonary Tuberculosis tracked by BioSniper.
What is the prevalence of Pulmonary Tuberculosis?
The estimated prevalence of Pulmonary Tuberculosis is approximately 30.0 per 100,000 population.
Deep-dive into Pulmonary Tuberculosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis